Beta Trials Platform | The Solution for Biotechs
Learn about our exclusive platform that allows biotechs to launch their clinical trials without an IND, with valid data for FDA submission and for a fraction of the cost compared to U.S. prices.
In this slide deck you will learn:
The advantages of conducting Phase I Trials outside the U.S.
Clinical Research Comparison between Mexico and Australia
How to submit trial data to the FDA without an IND